Clearday, INC

Market Movers (8-K)

OTC.Pink
CLRD
Clearday, INC
8-K: Clearday Director Resigns Amidst Business Combination Plans
Clearday, Inc. announces the resignation of director Jeffrey A. Coleman, while also planning to add a new director to support its merger with Viveon Healthcare Acquisition Corp.
OTC.Pink
CLRD
Clearday, INC
8-K: Clearday Secures $1.558 Million Financing via Promissory Note and Warrants
Clearday, Inc. has entered into a securities purchase agreement resulting in $1.558 million in financing through a promissory note and warrants.
Capital raise
OTC.Pink
CLRD
Clearday, INC
8-K: Clearday Inc. Amends Promissory Note, Increasing Debt to $3.89 Million
Clearday Inc. has amended a promissory note, increasing its debt to $3.89 million to reflect additional obligations under a lease transition agreement.
Worse than expected
OTC.Pink
CLRD
Clearday, INC
8-K: Clearday Secures Additional Funding and Amends Loan Terms with Mast Hill Fund
Clearday, Inc. amended its loan agreement with Mast Hill Fund, securing additional financing, extending maturity dates, and issuing a new warrant.
Worse than expected
Capital raise
OTC.Pink
CLRD
Clearday, INC
8-K: Clearday Inc. Faces Foreclosure on Naples Property Following Final Judgement
Clearday Inc. and its CEO are facing a foreclosure sale of their Naples, Florida property after a final judgement was entered against them for $6.18 million plus interest.
Worse than expected
Capital raise

Quarterly Earnings (10-Q)

OTC.Pink
CLRD
Clearday, INC
10-Q: Clearday, Inc. Reports Q3 2023 Results, Navigating Transition and Pursuing Viveon Merger
Clearday, Inc. reports a significant decrease in revenue and operating expenses for Q3 2023 as it transitions its business model and pursues a merger with Viveon Health Acquisition Corp.
Capital raise
Worse than expected